Growth-promoting therapies

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE (ESPE 2015)

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Barcelona, Spain; 1-3 October 2015 Further information

Free Communications

Previous section
Gonads & DSD

Table of contents

Next section
Obesity - Basic

hrp0084fc7.1 | Growth-promoting therapies

Safety and Effectiveness of Increlex® Therapy in Children with Laron Syndrome and Enrolled in the European Increlex® Growth Forum Database in Europe

hrp0084fc7.2 | Growth-promoting therapies

Topicon™ ThermoMatrix™-Mediated Passive Transdermal Delivery of IGF1 Across EpidermFT Full-Thickness Human Skin Equivalent: Towards an Extended-Wear IGF1 Patch

hrp0084fc7.3 | Growth-promoting therapies

IGF1 Levels, Complex Formation, and IGF-Bioactivity in GH-Treated Children with Prader–Willi Syndrome

hrp0084fc7.4 | Growth-promoting therapies

A Novel Reversible Albumin-Binding GH Derivative Possesses a Promising Once-Weekly Treatment Profile in Children with GH Deficiency

hrp0084fc7.5 | Growth-promoting therapies

12-Month Safety and Efficacy of a Weekly Long-Acting GH (MOD-4023) Compared to Daily Recombinant Human GH Therapy in Pre-Pubertal GH-Deficient Children; Phase 2 Study: Study CP-4-004 Summary

hrp0084fc7.6 | Growth-promoting therapies

Pharmacokinetic and Pharmacodynamics Modelling of MOD-4023 (a Long-Acting Human GH) in GH-Deficient Children

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts